Chemoattraction, adhesion and activation of natural killer cells are involved in the antitumor immune response induced by fractalkine/CX3CL1.

[1]  Taoyong Chen,et al.  Fractalkine transgene induces T‐cell‐dependent antitumor immunity through chemoattraction and activation of dendritic cells , 2003, International journal of cancer.

[2]  E. Régulier,et al.  Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity , 2002, Gene Therapy.

[3]  R. Biassoni,et al.  Human natural killer cells: their origin, receptors and function , 2002, European journal of immunology.

[4]  G. Trinchieri,et al.  Reciprocal Activating Interaction between Natural Killer Cells and Dendritic Cells , 2002, The Journal of experimental medicine.

[5]  L. Zitvogel.  Dendritic and Natural Killer Cells Cooperate in the Control/Switch of Innate Immunity , 2002, The Journal of experimental medicine.

[6]  M. Robertson.  Role of chemokines in the biology of natural killer cells , 2002, Journal of leukocyte biology.

[7]  H. Nagawa,et al.  Peripheral blood dendritic cells, but not monocyte-derived dendritic cells, can augment human NK cell function. , 2001, Cellular immunology.

[8]  Adelheid Cerwenka,et al.  Natural killer cells, viruses and cancer , 2001, Nature Reviews Immunology.

[9]  S. Sone,et al.  Human monocyte‐derived and CD83+ blood dendritic cells enhance NK cell‐mediated cytotoxicity , 2001, European journal of immunology.

[10]  Xuetao Cao,et al.  The Involvement of TNF-α-Related Apoptosis-Inducing Ligand in the Enhanced Cytotoxicity of IFN-β-Stimulated Human Dendritic Cells to Tumor Cells1 , 2001, The Journal of Immunology.

[11]  Kenneth M. Murphy,et al.  Dendritic cell regulation of TH1-TH2 development , 2000, Nature Immunology.

[12]  C. Caux,et al.  Antitumor Effects of the Mouse Chemokine 6Ckine/SLC Through Angiostatic and Immunological Mechanisms1 , 2000, The Journal of Immunology.

[13]  M. Burdick,et al.  CXC chemokines in angiogenesis , 2000, Journal of leukocyte biology.

[14]  R. Crystal,et al.  Macrophage inflammatory protein 3alpha transgene attracts dendritic cells to established murine tumors and suppresses tumor growth. , 2000, The Journal of clinical investigation.

[15]  M. Burdick,et al.  Secondary Lymphoid Tissue Chemokine Mediates T Cell-Dependent Antitumor Responses In Vivo1 , 2000, The Journal of Immunology.

[16]  A. Yamauchi,et al.  Fractalkine-Mediated Endothelial Cell Injury by NK Cells1 , 2000, The Journal of Immunology.

[17]  Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma. , 1999, Cancer research.

[18]  X. Cao,et al.  Enhanced antitumor effects of bone marrow transplantation in combination with fibroblast-mediated IL-2 and IL-3 gene therapy. , 1999, Transplantation.

[19]  I. Charo,et al.  Molecular Uncoupling of Fractalkine-mediated Cell Adhesion and Signal Transduction , 1999, The Journal of Biological Chemistry.

[20]  F. Graham,et al.  Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer models. , 1999, Human gene therapy.

[21]  W. Gong,et al.  Chemokines and their role in tumor growth and metastasis. , 1998, Journal of immunological methods.

[22]  D. Patel,et al.  Fractalkine and CX3CR1 Mediate a Novel Mechanism of Leukocyte Capture, Firm Adhesion, and Activation under Physiologic Flow , 1998, The Journal of experimental medicine.

[23]  D. Lo,et al.  In Vivo Inhibition of CC and CX3C Chemokine–induced Leukocyte Infiltration and Attenuation of Glomerulonephritis in Wistar-Kyoto (WKY) Rats by vMIP-II , 1998, The Journal of experimental medicine.

[24]  N. Copeland,et al.  Cloning and characterization of a new type of mouse chemokine. , 1998, Genomics.

[25]  T. Schall,et al.  Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion , 1997, Cell.

[26]  Wei Wang,et al.  A new class of membrane-bound chemokine with a CX3C motif , 1997, Nature.

[27]  W. Lutz,et al.  Decreased tumor surveillance in perforin-deficient mice , 1996, The Journal of experimental medicine.

[28]  D. Margulies,et al.  Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. , 2002, Annual review of immunology.